ViroCell to present at 2024 Cell & Gene Meeting on the Med

Contributed by: Business Wire

Tags

Health

Stem Cells

Genetics

Clinical Trials

Pharmaceutical

Biotechnology

2024 Cell & Gene Meeting

More Like This

ViroCell Biologics to Host Panel Event at 2024 Cell & Gene Meeting on the Mesa

ViroCell Biologics Completes Oversubscribed Financing

ViroCell Biologics Signs Master Services Agreement With Prominent NCI-Designated Cancer Center

ViroCell and Great Ormond Street Hospital Poised to Unlock Clinical Trial ‘Backlog’ Following MHRA Manufacturing Approval

PR Newswire associated0

FibroBiologics to Provide Company Update at Upcoming Conferences

Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

Senior life science and medical specialists join SmartCella's Board of Directors